Delivery Order SPE2DB22D9367-SPE2DB25FSZ20
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $11,683.02 by the Defense Logistics Agency (DLA) on August 18, 2025. The contract calls for the delivery of Xtandi 80 mg tablets (60-count units), an oncology medication used in cancer treatment, with an ultimate completion date of August 19, 2025. This delivery order was issued without a set-aside designation, allowing the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $8,622.72 by the Defense Logistics Agency (DLA) on June 2, 2025, with an ultimate completion date of June 3, 2025. The contract, numbered 4568429678, involves the delivery of 120 capsules of Xtandi 40 mg, an oncology medication used in the treatment of prostate cancer. This delivery order was issued without set-aside...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $4,169.59 by the Defense Logistics Agency (DLA) on July 22, 2025. The contract, which carries no set-aside designation, calls for the delivery of 60 tablets of Xtandi 80 mg, an oncology medication used in cancer treatment. This delivery order represents one of many pharmaceutical supply orders issued under DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $8,339.18 by the Defense Logistics Agency's Medical Supply Chain on September 10, 2025. The delivery order, which expires September 11, 2025, covers 60 tablets of Xtandi 80 mg, an oncology medication used to treat advanced prostate cancer. This award was issued without a set-aside designation, demonstrating the company's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $8,622.72 by the Defense Logistics Agency (DLA) on August 18, 2025. The delivery order, which carries a firm fixed-price structure with an ultimate completion date of August 19, 2025, is for 120 capsules of Xtandi 40 mg, an oncology medication used in cancer treatment. This award was issued without a set-aside designation, demonstrating the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $8,339.18 by the Defense Logistics Agency (DLA) on August 18, 2025. The contract calls for the supply of 60 tablets of Xtandi 80 mg, an oncology medication used in cancer treatment. This delivery order is issued without a set-aside designation and carries an ultimate completion date of August 19, 2025, with performance to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a firm fixed-price delivery order valued at $8,339.18 from the Defense Logistics Agency (DLA) on September 12, 2025. The contract calls for the delivery of Xtandi 40 mg tablets in a quantity of 120 units, with an ultimate completion date of September 15, 2025. This delivery order was issued without a set-aside designation, allowing the company to compete on an...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $4,169.59 by the Defense Logistics Agency on September 9, 2025, with an ultimate completion date of September 10, 2025. The delivery order covers 120 tablets of Xtandi 40 mg, an oncology medication used in the treatment of prostate cancer. This award was issued without a set-aside designation, allowing the vendor to compete...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $4,839.02 by the Defense Logistics Agency (DLA) Medical Supply Chain on September 2, 2025, with an ultimate completion date of September 3, 2025. The delivery order is for Xtandi 40mg capsules (120 count), a prescription oncology medication, under a firm fixed-price contract type with no set-aside designation. This award represents a single...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $8,622.72 by the Defense Logistics Agency's Medical Supply Chain on September 18, 2025, with an ultimate completion date of September 19, 2025. The delivery order is for 120 capsules of Xtandi 40 mg, an oncology medication used in the treatment of advanced prostate cancer. This award was issued without a set-aside...
- SPE2DB22D9367Indefinite Delivery Contract
- SPE2DB22D9367-SPE2DB25FSZ20Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $8,339.18 by the Defense Logistics Agency (DLA) on August 14, 2025. The contract calls for the delivery of Xtandi 80 mg tablets (60-count supply), an oncology medication used in prostate cancer treatment. This delivery order carries an ultimate completion date of August 15, 2025, and was awarded without a set-aside designation, reflecting the company's competitive standing in federal pharmaceutical procurement. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at $499,999,999 and valid through November 2026. The IDC, established under the SPE2DB program, authorizes the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting the medical supply needs of Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group's extensive contract portfolio with DLA demonstrates its established role as a critical supplier in the federal pharmaceutical supply chain, providing branded and generic prescription drugs, biologics, and medical consumables to military health facilities across the nation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.3k | 8/14/25 |